Zoledronic acid
Once-a-year bone infusion for osteoporosis and cancer bone disease.
- Starts working
- Days (blood calcium); months (bone density)
- Half-life
- Biphasic; bound to bone for years
- In use since
- —
- Pregnancy
- Usually avoided
Overview
Zoledronic acid is a potent bisphosphonate given by IV drip. A yearly infusion treats osteoporosis; more frequent infusions treat high calcium and bone metastases in cancer.
Conditions it's used for
How it works
Slows bone breakdown so bones stay denser.
Zoledronic acid belongs to the Bisphosphonates. How Bisphosphonates work: bind to bone and stop the cells that break bone down.
Uses
- Osteoporosis
- Paget's disease
- High calcium in cancer
- Bone metastases and myeloma
Available as: iv infusion.
Typical dose
- Adults
- 5 mg IV once a year for osteoporosis; 4 mg every 3–4 weeks for cancer bone disease.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Flu-like symptoms for 1–3 days
- Muscle and bone pain
- Headache
- Low calcium
Serious — get medical help
Uncommon, but need prompt attention
- Jaw osteonecrosis (rare)
- Thigh bone fractures (rare)
- Kidney injury
- Atrial fibrillation (rare)
Warnings
- Check vitamin D and calcium first
- Dental check-up before starting
Who should avoid it
- Low calcium
- Creatinine clearance under 35 mL/min
- Pregnancy
Interactions
- Aminoglycosides — worsen low calcium and kidney effects
- NSAIDs and diuretics — kidney strain
- Calcium-lowering medicines — extra drop in calcium
Other medicines in the atlas that need care with Zoledronic acid, grouped by the reason:
Absorption blockedModerateWith Aluminium hydroxide, Calcium carbonate, Ferrous sulfate, Magnesium hydroxide, Sucralfate and 1 more
Calcium, iron, zinc and antacids bind this medicine in the gut so much less is absorbed.
What's usually done: Separate doses — usually 2–4 hours apart (levothyroxine 4 hours).
Using it safely
- Alcohol
- Best to limit. Alcohol harms bones; drink in moderation.
- Food and drink
- Drink plenty of fluids before and after the infusion.
- If you miss a dose
- Contact your clinic to rebook.
- Stopping it
- Single yearly doses.
- Driving
- Flu-like symptoms may affect alertness for 1–2 days.
- Tests and checks
- Calcium and vitamin D; Kidney function; Dental health
- If too much is taken
- Low calcium, kidney damage and fever. Hospital care needed.
- Storage
- Room temperature before opening.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
Not for use in pregnancy.
Breastfeeding
Usually avoided
Not recommended.
Special groups
- Kidney disease
- Avoid under 35 mL/min; check kidney function before each dose.
- Older adults
- Check kidney function and hydration.
Brand names
- United States
- Reclast, Zometa
- United Kingdom
- Aclasta, Zometa
- India
- Zoldria, Aclasta
- Australia
- Aclasta, Zometa
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Zoledronic acid?
Yes — Zoledronic acid is prescription-only in most countries.
Can I take Zoledronic acid during pregnancy?
Usually avoided. Not for use in pregnancy. Always check with a doctor or midwife.
How quickly does Zoledronic acid work?
Days (blood calcium); months (bone density).
Related medicines
Alendronic acid
Weekly tablet that strengthens bones.
RxBisphosphonatesDenosumab
Twice-yearly bone-strengthening injection.
RxRANKL inhibitorsRisedronate
Weekly or monthly bisphosphonate tablet for osteoporosis.
RxBisphosphonatesIbandronic acid
Monthly tablet or 3-monthly injection for osteoporosis.
RxBisphosphonates
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — M05BA08
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.